Expertise in
6
conditions

Dr. Maricar F. Malinis

Infectious Disease
Radiology And Biomedical Imaging-New Haven-Yale Physicians Building
800 Howard Ave, 
New Haven, CT 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
Radiology And Biomedical Imaging-New Haven-Yale Physicians Building
800 Howard Ave, 
New Haven, CT 

Overview

Maricar Malinis is an Infectious Disease provider practicing medicine in New Haven, Connecticut.

Dr. Malinis is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Cytomegalovirus Infection, HIV/AIDS, Cytomegalic Inclusion Disease, Severe Acute Respiratory Syndrome (SARS), and Tissue Biopsy.

She is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 6 clinical trials. Dr. Malinis is currently accepting new patients.

Specialties

Infectious Disease

Licenses

Internal Medicine in TN

Hospital Affiliations

Vanderbilt University Medical Center

Languages Spoken

English
Filipino

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Radiology And Biomedical Imaging-New Haven-Yale Physicians Building
800 Howard Ave, New Haven, CT 06519

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Enrollment Status: Completed
Publish Date: September 03, 2026
Intervention Type: Other
Study Phase: Not Applicable
HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Enrollment Status: Completed
Publish Date: July 20, 2026
Intervention Type: Other
Study Phase: Not Applicable
Observational Study of HIV+ Deceased Donor Solid Organ Transplant for HIV+ Recipients
Observational Study of HIV+ Deceased Donor Solid Organ Transplant for HIV+ Recipients
Enrollment Status: Completed
Publish Date: August 14, 2025
Intervention Type: Other
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
View 5 Less Clinical Trials

117 Total Publications

A Case of Gastrointestinal Mucormycosis in a Critically Ill Patient.
A Case of Gastrointestinal Mucormycosis in a Critically Ill Patient.
Journal: Cureus
Published: May 12, 2026
Similar Doctors
Expertise in
3
conditions
Dr. Michael T. Cappello
Infectious Disease
Expertise in
3
conditions
Dr. Michael T. Cappello
Infectious Disease
Referral may be required

Yale New Haven Childrens Hospital

1 Park St, 
New Haven, CT 
 (0.1 miles away)
203-785-4730
Languages Spoken:
English
See accepted insurances

Michael Cappello is an Infectious Disease provider practicing medicine in New Haven, Connecticut. Dr. Cappello is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Hookworm Infection, Secernentea Infections, Helminthiasis, and Malaria.

Expertise in
2
conditions
Dr. Manisha Juthani-Mehta
Infectious Disease
Expertise in
2
conditions
Dr. Manisha Juthani-Mehta
Infectious Disease
Referral may be required

Yale New Haven Hospital

20 York St, 
New Haven, CT 
 (0.1 miles away)
203-785-2140
Languages Spoken:
English
See accepted insurances

Manisha Juthani-Mehta is an Infectious Disease provider practicing medicine in New Haven, Connecticut. Dr. Juthani-Mehta is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, and Hospital-Acquired Pneumonia.

Expertise in
9
conditions
Dr. Gary P. Wormser
Infectious Disease
Expertise in
9
conditions
Dr. Gary P. Wormser
Infectious Disease
Referral may be required

Westchester County Health Care Corporation

100 Woods Rd, 
Valhalla, NY 
 (47.5 miles away)
914-493-7000
Languages Spoken:
English
See accepted insurances

Gary Wormser is an Infectious Disease provider practicing medicine in Valhalla, New York. Dr. Wormser is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lyme Disease, Babesiosis, Human Granulocytic Ehrlichiosis, Ehrlichiosis, and Splenectomy.

Frequently Asked Questions about Dr. Maricar F. Malinis

How do I make an appointment with Dr. Maricar F. Malinis?

You can book an appointment with Dr. Maricar F. Malinis by calling their office at 203-785-3561. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Maricar F. Malinis a top-rated expert for Cytomegalovirus Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maricar F. Malinis is classified as an Distinguished expert for Cytomegalovirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Maricar F. Malinis specialize in?

While Dr. Maricar F. Malinis is a Infectious Disease, they have specific expertise in Cytomegalovirus Infection, HIV/AIDS, and Cytomegalic Inclusion Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Maricar F. Malinis participate in research or clinical trials?

Yes. Dr. Maricar F. Malinis has published 117 articles and abstracts on conditions like Cytomegalovirus Infection. You can view a list of Dr. Maricar F. Malinis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Maricar F. Malinis accept my insurance?

Dr. Maricar F. Malinis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 203-785-3561 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Malinis's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile